Last reviewed · How we verify
A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
The aim of this study is to evaluate the impact of Ibrutinib monotherapy in the QoL of subjects with Chronic Lymphocytic Leukemia (CLL) based in European Quality of Life 5 Dimensions (EQ-5D) and FACIT- fatigue questionnaires assessment from baseline to 1 year of treatment in Argentinian routine clinical practice.
Details
| Lead sponsor | Mela Osorio Maria Jose |
|---|---|
| Status | COMPLETED |
| Enrolment | 50 |
| Start date | Mon Aug 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Oct 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- CLL
Interventions
- Standard of Care
Countries
Argentina